Aberrant gut-microbiota-immune-brain axis development in premature neonates with brain damage
David Seki(University of Vienna), Lukas Wisgrill(Universität Innsbruck), David Berry(University of Vienna), Bela Hausmann(Medical University of Vienna), Tom Van de Wiele(Ghent University), Benedikt Warth(University of Vienna), Gregor Kasprian(Medical University of Vienna), Katrin Klebermaß-Schrehof(Medical University of Vienna), Andreas Spittler(Medical University of Vienna), Petra Pjevac(University of Vienna), Vito Giordano(Comprehensive Cancer Center Vienna), Kim De Paepe(Ghent University), Angelika Berger(Medical University of Vienna), Margareta Mayer(University of Vienna), Lukas Unterasinger(Medical University of Vienna), Katharina Goeral(Comprehensive Cancer Center Vienna)
Cited by 177
Related Papers
METLIN: A Technology Platform for Identifying Knowns and Unknowns
|Analytical Chemistry|2018|951
Butyrate-producing<i>Clostridium</i>cluster XIVa species specifically colonize mucins in an<i>in vitro</i>gut model
|The ISME Journal|2012|639
European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update
|Neonatology|2023|638
Propionate as a health-promoting microbial metabolite in the human gut
|Nutrition Reviews|2011|578
Metabolomics activity screening for identifying metabolites that modulate phenotype
|Nature Biotechnology|2018|501